# Effect of GLP-1 on Angiogenesis

> **NCT02686177** · PHASE4 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 50 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Metformin or sulfonylurea

## Key facts

- **NCT ID:** NCT02686177
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-18
- **Primary completion:** 2017-08-08
- **Final completion:** 2021-05-28
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02686177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02686177, "Effect of GLP-1 on Angiogenesis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02686177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*